Welcome to our dedicated page for HeartCore Enterprises SEC filings (Ticker: HTCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HeartCore Enterprises, Inc. files regulatory reports that document material events for its IPO consulting business, capital structure, governance and Nasdaq listing status. Recent Form 8-K disclosures include operating-results releases, the treatment of HeartCore Co., Ltd. as discontinued operations following its divestiture, and information about the company’s transition toward financial services and capital markets-related activities.
The filings also record amendments to the company’s certificate of incorporation and bylaws, the completed reverse stock split, share-repurchase authorization, Regulation FD exhibits, and notices related to Nasdaq minimum bid price compliance for HTCR common stock.
Schedule 13G Highlights – Heartcore Enterprises, Inc. (HTCR)
Crom Structured Opportunities Fund I, LP (the “Reporting Person”) disclosed a 5.6 % beneficial ownership of Heartcore Enterprises, Inc. common stock as of 30 June 2025. The filing, made on 14 July 2025, triggers Schedule 13G reporting because the stake exceeds the 5 % threshold.
- Shares owned: 1,235,437 common shares
- Sole voting & dispositive power: 1,235,437 shares; no shared power
- Convertible preferred: The fund also holds 2,000 Series A Convertible Preferred shares. Conversion is subject to a 4.99 % ownership blocker, so no additional common shares are currently counted.
- Ownership basis: Percentage calculated against 22,075,033 outstanding common shares (Issuer data as of 15 May 2025).
- Intent: The certification states the securities were not acquired to influence control of the issuer, indicating a passive investment posture.
Investor Significance
The appearance of a new 5 %+ holder can be material for market perception, signalling external interest in HTCR’s equity. However, the filing contains no information on purchase price, strategic plans or future transactions. Potential dilution could arise if the 4.99 % blocker is waived and the preferred shares are converted, but that would require a separate filing once the threshold is crossed.